Spero Therapeutics, Inc. ($SPRO)
Rajavelu Esther โ Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
18,442
Price
$2.20
Total Value
$40,572.40
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Rajavelu Esther |
|---|---|
| Title | Chief Executive Officer, Chief Financial Officer and Chief Business Officer |
| Transaction Date | Feb 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Shares Sold | 18,442 |
| Price per Share | $2.20 |
| Total Value | $40,572.40 |
| Shares Owned After | 1,100,008 |
| Derivative | No |
| Accession Number | 0001193125-26-038184 |
| Document | View SEC Filing |